Herein we describe rational combinations of TNPs with immunotherapy, poly(ADP‐ribose) polymerase (PARP) inhibitors, and ADT/AR pathway inhibitors with special emphasis on principles of design, sequencing, and translation for PCa. This evidence concerns the gene AR and posterior cortical atrophy.